Issued Patents All Time
Showing 1–19 of 19 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12240938 | 2,2-dimethyl-1,3-dioxolan-4-yl-methyl 2-bromo-2,2-difluoroacetate, waterborne polyurethane, and preparation methods thereof | Shengpeng Wang, Bajin Chen, Jinxing Song, Pengfei Zhang, Xiaojun Wang +3 more | 2025-03-04 |
| 11577228 | Porous layered transition metal dichalcogenide and preparation method and use thereof | Cheng-Wen Wang, Huilin Zheng, Pengfei Zhang, Hongyun Shen, Xiaoling Li | 2023-02-14 |
| 11414415 | 6H-imidazo[4,5,1-ij]quinolone, synthesis method and use thereof | Pengfei Zhang, Wei-Che Huang, Chao Shen, Jun Xu, Jiabin Shen | 2022-08-16 |
| 11242307 | Method for preparing alkynyl 2-halo-2,2-difluoroacetate | Pengfei Zhang, Shengpeng Wang, Wanmei Li, Bajin Chen, Xiaojun Wang | 2022-02-08 |
| 11161818 | Quinolone derivatives, preparation methods and application thereof | Pengfei Zhang, Wanmei Li, Haifeng Wu | 2021-11-02 |
| 11161809 | Processes for preparing 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile and for preparing sulindac | Wanmei Li, Lianzhi Tao, Pengfei Zhang, Hongyun Shen, Dongxiang Feng | 2021-11-02 |
| 10611721 | Method for preparing levobunolol hydrochloride | Pengfei Zhang, Dongxiang Feng, Lianzhi Tao | 2020-04-07 |
| 10604466 | Method for preparing resveratrol compound | Wanmei Li, Xiaoling Li, Pengfei Zhang, Jinsong Wang, Kejie Chai | 2020-03-31 |
| 10125119 | Series of resveratrol-derivative fluorescently labeled molecules and synthesis method thereof | Pengfei Zhang, Wanmei Li, Kui Du, Kejie Chai | 2018-11-13 |
| 10004735 | Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines | Kimberly Fultz, Tam Minh Tran, Shuichan Xu | 2018-06-26 |
| 9737535 | Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines | Kimberly Fultz, Tam Minh Tran, Shuichan Xu | 2017-08-22 |
| 9557338 | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for tor kinase inhibitory activity | Deborah Mortensen, Shuichan Xu, Kimberly Fultz | 2017-01-31 |
| 9555033 | Identification of LKB1 mutation as a predictive biomarker for sensitivity to TOR kinase inhibitors | Rajesh Chopra, Yuhong Ning, Sabita Sankar, Shuichan Xu | 2017-01-31 |
| 9155736 | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity | Deborah Mortensen, Shuichan Xu, Kimberly Fultz | 2015-10-13 |
| 8507492 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more | 2013-08-13 |
| 8492381 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more | 2013-07-23 |
| 8394832 | Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders | Laura Corral | 2013-03-12 |
| 8110578 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, Roy L. Harris, John Sapienza, Graziella I. Shevlin, Patrick Papa +12 more | 2012-02-07 |
| 6197509 | Method of analyzing DNA using contiguous repeats | — | 2001-03-06 |